Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins

Neuregulin-1 (NRG1) is a potential therapeutic agent for the treatment of doxorubicin (Dox)-induced heart failure. NRG1, however, activates the erbB2 receptor, which is frequently overexpressed in breast cancers. It is, therefore, important to understand how NRG1, via erbB2, protects the heart again...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bian, Yun, Sun, Maoyun, Silver, Marcy, Ho, Kalon K. L., Marchionni, Mark A., Caggiano, Anthony O., Stone, James R., Amende, Ivo, Hampton, Thomas G., Morgan, James P., Yan, Xinhua
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2009
Assuntos:
Translational Physiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2793128/
https://ncbi.nlm.nih.gov/pubmed/19801490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.01010.2008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados